A citation-based method for searching scientific literature

Cholatip Wiratkapun, Pachara Patanajareet, Bussanee Wibulpholprasert, Panuwat Lertsithichai. Jpn J Radiol 2011
Times Cited: 7







List of co-cited articles
40 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
54
71

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Sophie Schulz, Peter Sinn, Michael Golatta, Geraldine Rauch, Hans Junkermann, Florian Schuetz, Christof Sohn, Joerg Heil. Breast 2013
38
57

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park,[...]. Breast 2012
43
57


Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Lisa A Rutstein, Ronald R Johnson, William R Poller, David Dabbs, Jan Groblewski, Tina Rakitt, Allan Tsung, Thomas Kirchner, Jules Sumkin, Donald Keenan,[...]. Breast J 2007
46
42


Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
227
42

Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
Tomohiro Miyake, Kenzo Shimazu, Hiroshi Ohashi, Tetsuya Taguchi, Satsuki Ueda, Takahiro Nakayama, Seung Jin Kim, Katsuyuki Aozasa, Yasuhiro Tamaki, Shinzaburo Noguchi. Am J Surg 2011
32
42

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Mary F Dillon, Enda W McDermott, Cecily M Quinn, Ann O'Doherty, Niall O'Higgins, Arnold D K Hill. J Surg Oncol 2006
73
42

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
C E Cox, K Nguyen, R J Gray, C Salud, N N Ku, E Dupont, L Hutson, E Peltz, G Whitehead, D Reintgen,[...]. Am Surg 2001
166
42


Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ.
Edna May L Go, Siu-Ki Chan, Joaquim S L Vong, Philip C W Lui, Anthony W H Chan, Tony K F Ma, Mark A Ang, Bonita K B Law, Puay-Hoon Tan, Gary M Tse. Mod Pathol 2010
19
42

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
35
42

Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Nehmat Houssami, Daniela Ambrogetti, M Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P Mamounas, Stefano Ciatto. Ann Surg Oncol 2011
30
42

Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy.
Jean-Charles Hogue, Lucie Morais, Louise Provencher, Christine Desbiens, Brigitte Poirier, Éric Poirier, Simon Jacob, Caroline Diorio. Anticancer Res 2014
17
42

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
200
42

MRI of the breast in patients with DCIS to exclude the presence of invasive disease.
Eline E Deurloo, Jincey D Sriram, Hendrik J Teertstra, Claudette E Loo, Jelle Wesseling, Emiel J Th Rutgers, Kenneth G A Gilhuijs. Eur Radiol 2012
23
28

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Amit Goyal, Anthony Douglas-Jones, Ian Monypenny, Helen Sweetland, Guy Stevens, Robert E Mansel. Breast Cancer Res Treat 2006
97
28


An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Caren Wilkie, Laura White, Elisabeth Dupont, Alan Cantor, Charles E Cox. Am J Surg 2005
93
28

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
206
28

Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions.
Steven Pandelidis, David Heiland, David Jones, Kelly Stough, Joanne Trapeni, Yasir Suliman. Ann Surg Oncol 2003
67
28


Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
253
28

Mammographic characteristics and vacuum-assisted breast biopsy (VABB) of non-palpable breast lesions.
Vincenzo Ventrella, Antonio Tufaro, Francesco A Zito, Maria Addante, Baldassarre Stea, Rosalba Dentamaro, Cosimo D'Amico, Angelo Paradiso. Acta Radiol 2011
5
40

A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
T A King, G H Farr, G J Cederbom, D H Smetherman, J S Bolton, A J Stolier, G M Fuhrman. Am Surg 2001
44
28

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
38
28

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
40
28

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
54
28

Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Laura Chin-Lenn, Lloyd A Mack, Walley Temple, William Cherniak, Robert R Quinn, Pietro Ravani, Adriane M Lewin, May Lynn Quan. Ann Surg Oncol 2014
25
28

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
485
28

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
28

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Elizabeth A Mittendorf, Cletus A Arciero, Veronica Gutchell, Jeff Hooke, Craig D Shriver. Curr Surg 2005
67
28

Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
Susan Prendeville, Ciara Ryan, Linda Feeley, Fionnuala O'Connell, Tara Jane Browne, Martin J O'Sullivan, Michael W Bennett. Breast 2015
24
28



A simple model to assess the probability of invasion in ductal carcinoma in situ of the breast diagnosed by needle biopsy.
Oldřich Coufal, Iveta Selingerová, Pavlína Vrtělová, Petr Krsička, Lucie Gabrielová, Pavel Fabian, Kateřina Stískalová, Monika Schneiderová, Alexandr Poprach, Ivan Justan. Biomed Res Int 2014
9
28

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Ah Young Park, Hye Mi Gweon, Eun Ju Son, Miri Yoo, Jeong-Ah Kim, Ji Hyun Youk. Eur J Radiol 2014
31
28

Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.
S C Doebar, C de Monyé, H Stoop, J Rothbarth, S P Willemsen, C H M van Deurzen. Breast 2016
21
28

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Takafumi Kondo, Naoki Hayashi, Sachiko Ohde, Koyu Suzuki, Atsushi Yoshida, Hiroshi Yagata, Naoki Niikura, Takayuki Iwamoto, Kumiko Kida, Michiko Murai,[...]. J Surg Oncol 2015
24
28


Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters.
Maki Hirano, Hiroko Satake, Satoko Ishigaki, Mitsuru Ikeda, Hisashi Kawai, Shinji Naganawa. AJR Am J Roentgenol 2012
78
14

Diffusion-weighted MRI as an adjunct to mammography in women under 50 years of age: an initial study.
Toshiki Kazama, Yoshifumi Kuroki, Mari Kikuchi, Yasunori Sato, Takeshi Nagashima, Yukimasa Miyazawa, Masahiro Sakakibara, Katsuhiko Kaneoya, Yumi Makimoto, Hideyuki Hashimoto,[...]. J Magn Reson Imaging 2012
22
14

Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?
Siwa Chan, Jeon-Hor Chen, Garima Agrawal, Muqing Lin, Rita S Mehta, Philip M Carpenter, Orhan Nalcioglu, Min-Ying Su. J Oncol 2010
20
14

Microinvasive carcinoma of the breast.
Simonetta Bianchi, Vania Vezzosi. Pathol Oncol Res 2008
52
14

Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.
Savannah C Partridge, Wendy B DeMartini, Brenda F Kurland, Peter R Eby, Steven W White, Constance D Lehman. AJR Am J Roentgenol 2009
180
14

Ductal carcinoma in situ of the breast.
M J Silverstein. Annu Rev Med 2000
43
14

Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment.
Kaiji Inoue, Eito Kozawa, Waka Mizukoshi, Junji Tanaka, Toshiaki Saeki, Takaki Sakurai, Fumiko Kimura. Jpn J Radiol 2011
20
14

Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Tsugumi Imamura, Ichiro Isomoto, Eijun Sueyoshi, Hiroshi Yano, Tatsuya Uga, Kuniko Abe, Tomayoshi Hayashi, Sumihisa Honda, Takuma Yamaguchi, Masataka Uetani. Magn Reson Med Sci 2010
51
14

Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
Savannah C Partridge, Christiane D Mullins, Brenda F Kurland, Michael D Allain, Wendy B DeMartini, Peter R Eby, Constance D Lehman. AJR Am J Roentgenol 2010
109
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.